Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-091751

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kalin Katherine Bach Director 2022-08-13 Grant or award · Stock Option (Right to Buy) +19,000 19,000 D: show line 1 in the form
Loading xslF345X03/tm2223585-1_4seq1.xml…